A mouse model for the evaluation of pathogenesis and immunity to influenza A (H5N1) viruses isolated from humans

Journal of Virology

Volumn 73, Issue 7, 1999, Pages 5903-5911

  Lu, Xiuhua ^a   Tumpey, Terrence M ^a   Morken, Timothy ^b   Zaki, Sherif R ^b   Cox, Nancy J ^a   Katz, Jacqueline M ^a  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM POTASSIUM SULFATE; DK SING VACCINE; INFLUENZA VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANIMAL CELL; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG POTENCY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFECTION PREVENTION; INFLUENZA VACCINATION; INFLUENZA VIRUS A; MALE; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; VIRUS IMMUNITY; VIRUS INACTIVATION; VIRUS ISOLATION; VIRUS PATHOGENESIS;

EID: 0033064858     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.7.5903-5911.1999     Document Type: Article

References (32)

1. Anonymous. 1997. Animals and animal products, p. 683-684. In Code of federal regulations. Office of the Federal Register, National Archives and Records Administration, Washington, D. C.
2. Bean, W. J., Y. Kawaoka, J. M. Wood, J. E. Pearson, and R. G. Webster. 1985. Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature. J. Virol. 54:151-160.
3. Bender, C., H. Hall, J. Huang, A. Klimov, N. Cox, A. Hay, V. Gregory, K. Cameron, W. Lim, and K. Subbarao. 1999. Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology 254:115-123.
4. Bender, C. Personal communication.
5. Centers for Disease Control and Prevention. 1997. Isolation of avian influenza A (H5N1) viruses from humans - Hong Kong, May-December. Morbid. Mortal. Weekly Rep. 46:1204-1207.
6. Centers for Disease Control and Prevention. 1998. Prevention and control of influenza. Recommendations of the advisory committee on immunization practices (ACIP). Morbid. Mortal. Weekly Rep. 47:1-26.
7. Centers for Disease Control and Prevention. 1998. Update: isolation of avian influenza A (H5N1) viruses from humans - Hong Kong, 1997-1998. Morbid. Mortal. Weekly Rep. 46:1245-1247.
8. Claas, E. C. J., A. D. M. E. Osterhaus, R. Van Beek, J. C. De Jong, G. F. Rimmelzwaan, D. A. Senne, S. Krauss, K. F. Shortridge, and R. G. Webster. 1998. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet 351:472-477.
9. Couch, R. B., J. A. Kasel, J. L. Gerin, J. L. Schulman, and E. D. Kilbourne. 1974. Induction of partial immunity to influenza by a neuraminidase-specific vaccine. J. Infect. Dis. 129:411-420.
10. Cox, N. J., and A. P. Kendal. 1984. Genetic stability of A/Ann/6/60 cold-mutant (temperature-sensitive) live influenza virus genes: analysis by oligonucleotide mapping of recombinant vaccine strains before and after replication in volunteers. J. Infect. Dis. 149:194-200.
11. De Jong, J. C., E. C. J. Class, A. D. M. E. Osterhaus, R. G. Webster, and W. L. Lim. 1998. A pandemic warning? Nature 389:554.
12. Deroo, T., W. M. Jou, and W. Fiers. 1996. Recombinant neuraminidase vaccine protects against lethal influenza. Vaccine 14:561-569.
13. Garcia, A., H. Johnson, DK. Srivastava, DA. Jayawardene, DR. Wehr, R. G. Webster. 1998. Efficacy of inactivated H5N1 influenza vaccines against A/Chicken/Queretaro/19/95 infection. Avian Dis. 42:248-256.
14. + T-cell repertoire of responses to influenza A virus hemagglutinin after recent natural infection. J. Virol. 69:7497-7506.
15. Gubareva, L. V., J. A. McCullers, R. C. Bethell, and R. G. Webster. 1998. Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of Zanamivir on H5N1 infection in mice. J. Infect. Dis. 178:1592-1596.
16. Harmon, M. W., P. A. Rota, H. H. Walls, and A. P. Kendal. 1988. Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection. J. Clin. Microbiol. 26:333-337.
17. Hinshaw, V. S., R. G. Webster, B. C. Easterday, W. J. Bean, Jr. 1981. Replication of avian influenza A viruses in mammals. Infect. Immun. 34: 354-361.
18. Hoyle, L. 1968. Adaptation of virus to mice, p. 170-171. In S. Gard, C. Hallauer, and K. F. Meyer (ed.), The influenza viruses. Springer-Verlag, New York, N.Y.
19. Katz, J. M., X. Lu, S. A. Young, and J. C. Galphin. 1997. Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine. J. Infect. Dis. 175:352-363.
20. Kendal, A. P., J. J. Skehel, and M. S. Pereira. 1982. Concepts and procedures for laboratory-based influenza surveillance, p. B17-B35. Centers for Disease Control, Atlanta, Ga.
21. Kodihalli, S., H. Goto, D. L. Kobasa, S. Krauss, Y. Kawaoka, and R. G. Webster. 1999. DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice. J. Virol. 73:2094-2098.
22. Matrosovich, M., N. Zhou, Y. Kawaoka, and R. Webster. 1999. The surface glycoproteins of H5 influenza viruses isolated from humans, chickens, and wild aquatic birds have distinguishable properties. J. Virol. 73:1146-1155.
23. Powers, D. C., G. E. Smith, E. L. Anderson, D. J. Kennedy, C. S. Hackett, B. E. Wilkinson, F. Volvovitz, R. B. Belshe, and J. J. Treanor. 1995. Influenza A virus vaccines contained purified recombinants H3 hemagglutinin are well tolerated and induced protective immune responses in healthy adults. J. Infect. Dis. 171:1595-1599.
24. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:493-497.
25. Richmond, J. Y., and R. W. Mckinney. 1993. Laboratory biosafety level criteria, p. 16-43. In J. Y. Richmond and R. W. Mckinney (ed.), Biosafety in microbiological and biomedical laboratories, 3rd ed. Centers for Disease Control, Atlanta, Ga.
26. Senne, D. A., B. Panigrapy, Y. Kawaoka, J. E. Pearson, J. Suss, M. Lipkind, H. Kida, and R. G. Webster. 1996. Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. Avian Dis. 40:425-437.
27. Shaw, M. Personal communication.
28. Shortridge, K. F., N. N. Zhou, Y. Guan, P. Gao, T. Ito, Y. Kawaoka, S. Kodihalll, S. Krauss, D. Markwell, K. G. Murti, M. Norwood, D. Senne, L. Sims, A. Takada, and R. G. Webster. 1998. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology 252:331-342.
29. Suarez, D. L., M. L. Perdue, N. J. Cox, T. Rowe, C. Bender, J. Huang, and D. E. Swayne. 1998. Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J. Virol. 72: 6678-6688.
30. Subbarao, K., A. Klimov, J. Katz, H. Regnery, W. Lim, H. Hall, M. Perdue, D. Swayne, C. Bender, J. Huang, M. Hemphill, T. Rowe, M. Shaw, X. Xu, K. Fukuda, and N. Cox. 1998. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science 279:393-396.
31. Yuen, K. Y., P. K. Chan, M. Peiris, D. N. C. Tsang, T. L. Que, K. F. Shortridge, P. T. Cheung, W. K. To, E. T. F. Ho, R. Sung, A. F. B. Cheng, and Members of the H5N1 Study Group. 1998. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 351:467-471.
32. Zaki, S. R., P. W. Greer, L. M. Coffield, C. S. Goldsmith, K. B. Nolte, K. Foucar, R. M. Feddersen, R. E. Zumwalt, G. L. Miller, A. S. Khan, P. E. Rollin, T. G. Ksizaek, S. T. Nichol, B. W. Mahy, and C. J. Peters. 1995. Hantavirus pulmonary syndrome: pathogenesis of an emerging infectious disease. Am. J. Pathol. 146:552-579.